Interferon-α and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation

Blood

Volumn 98, Issue 5, 2001, Pages 1594-1600

  Cavet, James ^a,b   Dickinson, Anne M ^a   Norden, Jean ^a   Taylor, Penelope R A ^a   Jackson, Graham H ^a   Middleton, Peter G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA; HLA ANTIGEN;

ADULT; ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DONOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INFLAMMATION; INTRON; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; EXON; GENETIC PREDISPOSITION; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; NUCLEAR FAMILY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ALLELES; BONE MARROW TRANSPLANTATION; COHORT STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; INTRONS; MALE; MICROSATELLITE REPEATS; NUCLEAR FAMILY; POLYMORPHISM, GENETIC; RISK FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0035438384     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.5.1594     Document Type: Article

References (55)

1. Hagglund H, Bostrom L, Remberger M, Ljungman P, Nilsson B, Ringden O. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplant. 1995;16:747-753.
2. Barrett AJ, van Rhee F. Graft-versus-leukaemia. Baillieres Clin Haematol. 1997;10:337-355.
3. Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 1990;75:2459-2464.
4. Ferrara JL, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host-disease [review]. Stem Cells. 1996;14:473-489.
5. Krenger W, Hill GR, Ferrara JL. Cytokine cascades in acute graft-versus-host disease [review]. Transplantation. 1997;64:553-558.
6. Roncarolo MG. The role of interleukin-10 in transplantation and GVHD. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-Versus-Host Disease. 2nd ed. New York: Marcel Dekker; 1997:693-715.
7. Korholz D, Kunst D, Hempel L, et al. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19:691-695.
8. Holler E, Roncarolo MG, Hintermeier-Knabe R, et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:237-241.
9. Velardi A, Varese P, Terenzi A, et al. Lymphokine production by T-cell clones after human bone marrow transplantation. Blood. 1989;74:1665-1672.
10. Niederwieser D, Herold M, Woloszczuk W, et al. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation. 1990;50:620-625.
11. Carayol G, Bourhis JH, Guillard M, et al. Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease. Transplantation. 1997;63:1307-1313.
12. Dickinson AM, Sviland L, Hamilton PJ, et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1994;13:65-70.
13. Brok HP, Heidt PJ, van der Meide PH, Zurcher C, Vossen JM. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol. 1993;151:6451-6459.
14. Murphy WJ, Welniak LA, Taub DD, et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest. 1998;102:1742-1748.
15. Yang YG, Qi J, Sykes M. IFN-gamma downmodulates graft-versus-host disease while mediating graft-versus-leukaemic effects. Blood. 1999;94:635a.
16. Imamura M, Hashino S, Kobayashi H, et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant. 1994;13:745-751.
17. Ochs LA, Blazar BR, Roy J, Rest EB, Weisdorf DJ. Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant. 1996;17:1085-1092.
18. Ruiz-Linares A. Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. Hum Mol Genet. 1993;2:1508.
19. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet. 1999;26:1-3.
20. Reynard MP, Turner D, Wadhwa M, Bird C, Navarrete CV. The influence of an IFN-gamma gene microsatellite on IFN-gamma production [abstract]. Immunology. 2000;61:S138.
21. Awad M, Pravica V, Perrey C, et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol. 1999;60:343-346.
22. Asderakis A, Sankaran D, Pravica V. High producer interferon gamma (IFNg) and interleukin 10 (IL-10) genotype is associated with increased frequency of acute rejection episodes in kidney transplant recipients. British Transplantation Society 1st Annual Congress, 1998.
23. Symington FW, Symington BE, Liu PY, Viguet H, Santhanam U, Sehgal PB. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation. 1992;54:457-462.
24. Abdallah AN, Boiron JM, Attia Y, Cassaigne A, Reiffers J, Iron A. Plasma cytokines in graft vs host disease and complications following bone marrow transplantation. Hematol Cell Ther. 1997;39:27-32.
25. Tanaka J, Imamura M, Kasai M, Sakurada K, Miyazaki T. Cytokine gene expression after allogeneic bone marrow transplantation. Leuk Lymphoma. 1995;16:413-418.
26. Lange A, Klimczak A, Karabon L, Suchnicki K. Cytokines, adhesion molecules (E-selectin and VCAM-1) and graft-versus-host disease. Arch Immunol Ther Exp 1995;43:99-105.
27. Bowcock AM, Kidd JR, Lathrop GM, et al. The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics. 1988;3:8-16.
28. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369-1376.
29. Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ, Welsh KI. Cytokine and cytokine receptor polymorphisms and acute rejection after renal transplantation [abstract]. Immunology. 2000;61:S2.
30. Bowcock AM, Ray A, Erlich H, Sehgal PB. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acids Res. 1989;17:6855-6864.
31. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone. 1997;21:89-92.
32. Linker-Israeli M, Wallace DJ, Prehn J, et al. Association of IL-6 genes with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun. 1999;1:45-52.
33. Middleton PG, Taylor PRA, Jackson G, Proctor SJ, Dickinson AM. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998;92:3943-3948.
34. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host-disease in HLA-matched sibling bone marrow transplants. Blood. 1999;94:3941-3946.
35. Kogler G, Wilke M, Middleton PG, et al. Cytokine gene polymorphism of the recipient influences the development of acute graft versus host disease in HLA mismatched cord blood transplants [abstract]. Bone Marrow Transplant. 2000;25:S4.
36. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int. 1999;56:281-288.
37. Dickinson AM, Sviland L, Carey P, et al. Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant. 1988;3:323-329.
38. Storb R, Deeg HJ, Whitehead J, et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-735.
39. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics. 1993;16:180-186.
40. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974;18:295-304.
41. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1989;4:247-254.
42. Turner DM, Grant SC, Lamb WR, et al. A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation. 1995;60:1113-1117.
43. Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus [published erratum appears in Tissue Antigens 1997 Dec;50(6):699]. Tissue Antigens 1997;49:635-639.
44. Weissensteiner T, Lanchbury JS. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics. 1997;47:6-16.
45. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 1995;80:41-45.
46. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93-97.
47. Carlens S, Ringden O, Remberger M, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22:755-761.
48. Brok HP, Vossen JM, Heidt PJ. Interferongamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice. Bone Marrow Transplant. 1997;19:601-606.
49. Xun C, Brown SA, Jennings CD, Henslee-Downey PJ, Thompson JS. Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice. Transplantation. 1993;56:409-417.
50. Ellison CA, HayGlass KT, Fischer JM, Rector ES, MacDonald GC, Gartner JG. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease. Transplantation. 1998;66:284-294.
51. Gifford GE, Lohmann-Matthes ML. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst. 1987;78:121-124.
52. Lichtman AH, Krenger W, Ferrara JLM. Cytokine networks. In: Ferrara JLM, Deeg HJ, Burakoff SJ, eds. Graft-Versus-Host Disease. New York: Marcel Dekker; 1997:179-218.
53. Easaw SJ, Lake DE, Beer M, Seiter K, Feldman EJ, Ahmed T. Graft-versus-host disease. Possible higher risk for African American patients. Cancer. 1996;78:1492-1497.
54. Klingemann HG, Deeg HJ, Self S, Thomas ED, Storb R. Is race a risk factor for allogeneic marrow transplantation? Bone Marrow Transplant. 1986;1:87-94.
55. Dickinson A, Hromadnikova I, Sviland L, et al. Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants-effect of GVHD prophylaxis. Bone Marrow Transplant. 1999;24:857-863.